Connecticut has prevailed in a lawsuit against pharmaceutical company McKesson alleging the company inflated drugs costs of its pharmaceutical drugs to increase its market share, according to a news report by The Day.
Uncategorized
A joint committee has proposed a set of final rules for Florida's pain clinics which would set restrictions on how much pain medication can be prescribed, according to a news report by The Ledger.
A federal appeals court has upheld prison sentences given to a Miami endocrinologist and nurse for their roles in a multimillion-dollar Medicare fraud scheme, according to a Bloomberg Businessweek news report.
The Office of the Inspector General has released a report suggesting medical schools are not complying with federal regulations requiring that medical school students receive training and education on Medicare and Medicaid fraud and abuse laws, according to the OIG…
Editor's note: The following article by Lindsay McQueeney Hanrahan, director, EHR product management for SourceMedical, was adapted and reprinted from the Fall 2010 edition of SourceMedical's "Insider Source" magazine. An electronic health record (EHR) system should not simply replicate…
Advertisement
TriMedx, a clinical engineering and technology asset management consulting firm, has announced the hiring of Tom Vorpahl as chief operating officer.
I. JOB SUMMARY: The Senior ASC Analyst supports the Sales and Operations team. This position acts as a liaison between Operations and Sales, assisting with sales strategy and communication and taking ownership of the business services assessment process.
Sandoz, the generics pharmaceutical division of pharmaceutical company Novartis, has agreed to pay the state of Idaho $1.65 million in a drug pricing lawsuit, according to a Bloomberg Businessweek news report.
A pharmacist from Lyndhurst, N.J., has been sentenced to three years in prison for fraudulently billing the federal Medicaid program, according to a New Jersey Newsroom report.
Pharmaceutical company Johnson & Johnson has lost a lawsuit in Louisiana that alleged the company made misleading claims about the safety of its antipsychotic drug Risperdal, ending in a $257.7 million loss for the pharmaceutical giant, according to a Bloomberg…